Growing studies determine that the upregulation of GPR34 is implicated in the onset and progression of various cancers, including triple negative breast cancer (TNBC), cervical cancer, colorectal cancer (CRC), MALT lymphoma, gastric cancer, glioma, and BCR/ABL-positive leukemia [23–29]. This evidence concerns the gene GPR34 and central nervous system cancer.